CHEOY vs ABT: Which Stock is Better?

Side-by-side comparison of CochLear Ltd ADR and Abbott Laboratories in 2026

Comparison Updated:

CHEOY

CochLear Ltd ADR

$63.68

ABT

Abbott Laboratories

$96.81

Key Metrics Comparison

MetricCHEOYABTWinner
Market Cap$8.50B$165.90BABT
P/E Ratio34.9226.74ABT
EPS (TTM)$1.86$3.57ABT
Revenue Growth-0.0%0.0%ABT
Gross Margin72.8%56.7%CHEOY

Analyze CHEOY

Full quant analysis

Analyze ABT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHEOY or ABT a better investment?

Comparing CHEOY and ABT: CochLear Ltd ADR has a market cap of $8.50B while Abbott Laboratories has $165.90B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHEOY and ABT?

CHEOY (CochLear Ltd ADR) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHEOY or ABT?

Based on P/E ratios, ABT trades at a lower multiple (26.7x vs 34.9x).

Which is growing faster: CHEOY or ABT?

ABT has higher revenue growth at 0.0% vs -0.0% for CHEOY.

Which company is more profitable: CHEOY or ABT?

CochLear Ltd ADR (CHEOY) has higher gross margins at 72.8% compared to 56.7% for ABT.

Which is the larger company: CHEOY or ABT?

Abbott Laboratories (ABT) is larger with a market cap of $165.90B compared to $8.50B for CHEOY.

Should I buy CHEOY or ABT in 2026?

Both CHEOY and ABT have investment merit. CHEOY trades at $63.68 while ABT trades at $96.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHEOY and ABT stock?

Key differences: Market Cap ($8.50B vs $165.90B), P/E Ratio (34.9x vs 26.7x), Revenue Growth (-0.0% vs 0.0%), Gross Margin (72.8% vs 56.7%).

Popular Stock Comparisons